These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1721553)

  • 1. Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality.
    Yoshioka T; Ichikawa I; Fogo A
    J Am Soc Nephrol; 1991 Oct; 2(4):902-12. PubMed ID: 1721553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular injury and proteinuria in rats after intrarenal injection of cobra venom factor. Evidence for the role of neutrophil-derived oxygen free radicals.
    Rehan A; Wiggins RC; Kunkel RG; Till GO; Johnson KJ
    Am J Pathol; 1986 Apr; 123(1):57-66. PubMed ID: 2421581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy.
    Yoshioka T; Shiraga H; Yoshida Y; Fogo A; Glick AD; Deen WM; Hoyer JR; Ichikawa I
    J Clin Invest; 1988 Nov; 82(5):1614-23. PubMed ID: 3183057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for angiotensin II in an overt functional proteinuria.
    Yoshioka T; Mitarai T; Kon V; Deen WM; Rennke HG; Ichikawa I
    Kidney Int; 1986 Oct; 30(4):538-45. PubMed ID: 2431191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible hexadimethrine-induced alterations in glomerular structure and permeability.
    Bridges CR; Rennke HG; Deen WM; Troy JL; Brenner BM
    J Am Soc Nephrol; 1991 Mar; 1(9):1095-108. PubMed ID: 1912408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries.
    Kawamura T; Yoshioka T; Bills T; Fogo A; Ichikawa I
    Kidney Int; 1991 Aug; 40(2):291-301. PubMed ID: 1942778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular permeability and polyanion in adriamycin nephrosis in the rat.
    Weening JJ; Rennke HG
    Kidney Int; 1983 Aug; 24(2):152-9. PubMed ID: 6195386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered anionic GBM components in monoclonal antibody against slit diaphragm-injected proteinuric rats.
    Fujigaki Y; Nagase M; Hidaka S; Matsui K; Shirai M; Nosaka H; Kawachi H; Shimizu F; Hishida A
    Kidney Int; 1998 Nov; 54(5):1491-500. PubMed ID: 9844125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular selective permeability to macromolecular neutral dextrans in experimental diabetes.
    Pennell JP; Yanagawa N; Hwang KH; Millard MM; Bourgoignie JJ
    Diabetologia; 1981 Mar; 20(3):223-7. PubMed ID: 6164592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular dysfunction induced by polymorphonuclear leukocyte-derived reactive oxygen species.
    Yoshioka T; Ichikawa I
    Am J Physiol; 1989 Jul; 257(1 Pt 2):F53-9. PubMed ID: 2750924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of oxygen radicals in phorbol myristate acetate-induced glomerular injury.
    Rehan A; Johnson KJ; Kunkel RG; Wiggins RC
    Kidney Int; 1985 Mar; 27(3):503-11. PubMed ID: 3999539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system.
    Johnson RJ; Couser WG; Chi EY; Adler S; Klebanoff SJ
    J Clin Invest; 1987 May; 79(5):1379-87. PubMed ID: 3033023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome.
    Remuzzi A; Schieppati A; Battaglia C; Remuzzi G
    Am J Kidney Dis; 1989 Sep; 14(3):170-7. PubMed ID: 2476029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular permeability to neutral and anionic dextrans in experimental diabetes.
    Michels LD; Davidman M; Keane WF
    Kidney Int; 1982 May; 21(5):699-705. PubMed ID: 6180213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathophysiology of protein-overload proteinuria.
    Weening JJ; Van Guldener C; Daha MR; Klar N; van der Wal A; Prins FA
    Am J Pathol; 1987 Oct; 129(1):64-73. PubMed ID: 3661680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular sieving of high molecular weight proteins in proteinuric rats.
    Bertolatus JA; Abuyousef M; Hunsicker LG
    Kidney Int; 1987 Jun; 31(6):1257-66. PubMed ID: 3613403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin II receptor blockade on remnant glomerular permselectivity.
    Mayer G; Lafayette RA; Oliver J; Deen WM; Myers BD; Meyer TW
    Kidney Int; 1993 Feb; 43(2):346-53. PubMed ID: 7680077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy.
    Carrie BJ; Myers BD
    Kidney Int; 1980 May; 17(5):669-76. PubMed ID: 6157049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanisms of proteinuria in aging rats.
    Baylis C; Fredericks M; Leypoldt J; Frigon R; Wilson C; Henderson L
    Mech Ageing Dev; 1988 Nov; 45(2):111-26. PubMed ID: 2462659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased albumin and normal dextran clearances in protein-overload proteinuria in the rat.
    Bliss DJ; Brewer DB
    Clin Sci (Lond); 1985 Sep; 69(3):321-6. PubMed ID: 2415293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.